Markets

Home | Market | Company Info | Income Statement

Get Quotes

Market Menu

INCOME STATEMENTS-Kwality Pharmaceuticals Ltd.

You can view the income statements for the last 5 years.

BSE

Apr 18

449.05 -3.30 ( -0.73%)

Volume 3776

Prev. Close 452.35

Open Price 445.00

Today's Low / High

445.00

466.95

Bid Price(Qty.) 0.00 (0)

Open Pr.(Qty.) 0.00 (0)

52 Wk Low / High

248.00

545.00

Kwality Pharmaceuticals Ltd.is not traded in NSE

ISIN No	INE552U01010	Market Cap. ( )	465.94	P/BV	2.33	Book Value ( )	192.48
BSE Code	539997	52 Week High/Low ( )	545/248	FV/ML	10/1	P/E(X)	24.05
NSE Code	-	Book Closure	30/09/2023	EPS ( )	18.67	Div Yield (%)	0.07

( )

Particulars	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	251.03	456.19	262.01	139.30	166.29
Total Operating Revenues	251.03	456.19	262.01	139.30	166.29

Other Income	2.94	3.51	1.59	3.66	0.61
Total Revenue	253.97	459.70	263.60	142.96	166.90

EXPENSES
Cost Of Materials Consumed	113.22	199.31	165.28	91.92	114.06
Purchase Of Stock-In Trade	0.04	3.80	0.22	0.67	0.13
Changes In Inventories Of FG,WIP And Stock-In Trade	-3.20	-2.51	0.09	-5.51	5.25
Employee Benefit Expenses	29.96	20.15	15.90	11.93	8.56
Finance Costs	6.02	2.92	2.67	2.50	2.28
Depreciation And Amortisation Expenses	14.96	10.69	6.49	4.43	3.12
Other Expenses	50.86	63.77	51.67	26.10	22.58
Total Expenses	211.87	298.13	242.33	132.04	155.99

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	42.10	161.57	21.27	10.92	10.91

Exceptional Items	-16.53	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	25.57	161.57	21.27	10.92	10.91

Tax Expenses-Continued Operations
Current Tax	6.48	41.00	5.80	3.00	3.30
Deferred Tax	0.14	0.27	0.16	-0.32	-0.09
Tax For Earlier Years	-0.33	0.35	0.42	0.03	0.14
Total Tax Expenses	6.29	41.63	6.38	2.71	3.35
Profit/Loss After Tax And Before ExtraOrdinary Items	19.28	119.94	14.89	8.21	7.56

Profit/Loss From Continuing Operations	19.28	119.94	14.89	8.21	7.56

Profit/Loss For The Period	19.28	119.94	14.89	8.21	7.56

Minority Interest	0.09	0.05	0.26	0.11	0.00
Consolidated Profit/Loss After MI And Associates	19.37	119.99	15.15	8.32	7.55

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	18.16	115.64	14.60	8.02	7.28
Diluted EPS (Rs.)	18.16	115.64	14.60	8.02	7.28

Particulars	Mar 23
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	251.03
Total Operating Revenues	251.03
Other Income	2.94
Total Revenue	253.97
EXPENSES
Cost Of Materials Consumed	113.22
Purchase Of Stock-In Trade	0.04
Changes In Inventories Of FG,WIP And Stock-In Trade	-3.20
Employee Benefit Expenses	29.96
Finance Costs	6.02
Depreciation And Amortisation Expenses	14.96
Other Expenses	50.86
Total Expenses	211.87
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	42.10
Exceptional Items	-16.53
Profit/Loss Before Tax	25.57
Tax Expenses-Continued Operations
Current Tax	6.48
Deferred Tax	0.14
Tax For Earlier Years	-0.33
Total Tax Expenses	6.29
Profit/Loss After Tax And Before ExtraOrdinary Items	19.28
Profit/Loss From Continuing Operations	19.28
Profit/Loss For The Period	19.28
Minority Interest	0.09
Consolidated Profit/Loss After MI And Associates	19.37
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	18.16
Diluted EPS (Rs.)	18.16